15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Xpeng Inc, 4 rate it Buy or better, 0 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $14.00 to $25.00, a moderate spread. The average target of $20.50 sits 94% above the current $10.55. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.41 next quarter toward $1.24 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy480%
Hold00%
Sell120%
Strong Sell00%
Based on 5 analysts giving stock ratings to Xpeng Inc.
As of Sep, 4 of 5 firms rate XPEV a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
XPEV EPS & revenue forecast
EPS · NEXT QUARTER
$0.41
Range $0.34 – $0.48 · 2 analysts · -21% YoY
Next period, 2 analysts expect Xpeng Inc to earn $0.41 a share (range $0.34 – $0.48), versus $0.52 a year earlier. Full-year consensus is $-3.46, growing to $1.24 the year after.
REVENUE · NEXT QUARTER
$31.0B
Range $24.9B – $34.3B · 2 analysts · +39% YoY
Revenue is expected to reach $31.0B (range $24.9B – $34.3B), +39.4% year-over-year. Full-year consensus is $87.3B, rising to $111.7B next year.
Top analysts covering Xpeng Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XPEV.
#1
Jiong Shao
Barclays · Rank #146
Sell
$14.00+32.6% to target
Overall win rate
45%
+ Follow
#2
EH
Eugene Hsiao
Macquarie
Buy
$19.00+80.0% to target
Coverage
—
+ Follow
#3
JC
Jeff Chung
Citigroup
Buy
$21.40+102.7% to target
Coverage
—
+ Follow
#4
NL
Nick Lai
JP Morgan
Buy
$24.00+127.4% to target
Coverage
—
+ Follow
#5
MH
Ming Hsun Lee
B of A Securities
Buy
$18.00+70.5% to target
Coverage
—
+ Follow
XPEV stock forecast FAQ
What is XPEV's average 12-month price target?+
The 4 analysts with a live target average $20.50 for Xpeng Inc over the next 12 months, ranging from a $25.00 high to a $14.00 low.
Is XPEV stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for XPEV?+
The Street-high target is $25.00 (Freedom Capital Markets), and the Street-low is $14.00 (Barclays). The average of all 4 active targets is $20.50.
How many Wall Street analysts cover XPEV?+
5 analysts have an active rating on Xpeng Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering XPEV?+
Among analysts who currently cover XPEV, Jiong Shao of Barclays has the strongest overall Quantellect track record (Rank #146). Their current call is Sell with a $14.00 target.
What is Xpeng Inc's projected EPS for next quarter?+
The consensus estimate is $0.41 per share (range $0.34 – $0.48) across 2 analysts. Full-year EPS is projected at $-3.46, rising to $1.24 the following year.
How much revenue is Xpeng Inc expected to report next quarter?+
Consensus revenue is $31.0B (range $24.9B – $34.3B). Full-year revenue is projected at $87.3B, growing to $111.7B next year.
Have analysts been upgrading or downgrading XPEV lately?+
As of Sep, 4 of 5 firms rate XPEV a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XPEV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
